Literature DB >> 25941961

Evaluation of Prognostic Nutritional Index in Patients Undergoing Radical Surgery with Nonsmall Cell Lung Cancer.

Chen Qiu1, Xiao Qu, Hongchang Shen, Chunlong Zheng, Linhai Zhu, Long Meng, Jiajun Du.   

Abstract

The prognostic nutritional index (PNI) has been reported to be a prognostic indicator in some malignant tumors. However, its prognostic value in nonsmall cell lung cancer (NSCLC) has not been fully investigated. A retrospective review of 1416 patients with NSCLC who underwent radical surgery between January 2006 and December 2011 was conducted. To obtain optimal cutoff levels of PNI, running log-rank statistics was applied. Survival was calculated by the Kaplan-Meier method. The prognostic significance of PNI, together with various clinicopathological factors, was evaluated by multivariate analysis. The optimal cutoff point for PNI was 52. The 1-, 3-, and 5-yr survival rates in patients with PNI of less than 52 were 80.0%, 61.3%, and 50.4%, respectively, and were significantly more unfavorable than those in patients with PNI 52 or higher (84.7%, 71.5%, and 60.3%, respectively, P < 0.001). Multivariate analysis suggested that gender (P = 0.026), age (P < 0.001), PNI (P = 0.005), differentiation (P = 0.024), pathology T category (P = 0.003), and pathology N category (P < 0.001) were revealed to be independent prognostic factors. Our results indicate that PNI is an independent predictor of survival for patients undergoing radical surgery with NSCLC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25941961     DOI: 10.1080/01635581.2015.1032430

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  9 in total

1.  Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?

Authors:  Yakup Bozkaya; Osman Köstek; Abdullah Sakin; Deniz Tataroğlu Özyükseler; Teoman Şakalar; İbrahim Çil
Journal:  Support Care Cancer       Date:  2019-08-30       Impact factor: 3.603

2.  Poor nutrition and sarcopenia are related to systemic inflammatory response in patients with rectal cancer undergoing preoperative chemoradiotherapy.

Authors:  Shinya Abe; Hiroaki Nozawa; Kazushige Kawai; Kazuhito Sasaki; Koji Murono; Shigenobu Emoto; Junko Kishikawa; Tsuyoshi Ozawa; Yuichiro Yokoyama; Yuzo Nagai; Hiroyuki Anzai; Hirofumi Sonoda; Soichiro Ishihara
Journal:  Int J Colorectal Dis       Date:  2021-10-11       Impact factor: 2.571

3.  Prognostic value of prognostic nutritional index in lung cancer: a meta-analysis.

Authors:  Dan Li; Xia Yuan; Jia Liu; Changling Li; Weimin Li
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

4.  Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer.

Authors:  Katsuhiko Shimizu; Riki Okita; Shinsuke Saisho; Ai Maeda; Yuji Nojima; Masao Nakata
Journal:  World J Surg Oncol       Date:  2015-09-30       Impact factor: 2.754

5.  Prognostic Dynamic Nomogram Integrated with Inflammation-Based Factors for Non-Small Cell Lung Cancer Patients with Chronic Hepatitis B Viral Infection.

Authors:  Shulin Chen; Xiaohui Li; Hui Lv; Xiaoyan Wen; Qiuying Ding; Ning Xue; Hongkai Su; Hao Chen
Journal:  Int J Biol Sci       Date:  2018-10-19       Impact factor: 6.580

6.  Log-transformed B-type natriuretic peptide as a prognostic predictor in patients undergoing cardiovascular surgery.

Authors:  Sho Takagi; Yuichiro Machida; Takashi Kobata; Daisuke Sakamoto; Shigeru Sakamoto; Tsugiyasu Kanda
Journal:  J Int Med Res       Date:  2018-11-14       Impact factor: 1.671

7.  Controlling Nutritional Status (CONUT) score is a prognostic factor in patients with resected breast cancer.

Authors:  Wen Li; Min Li; Ting Wang; Guangzhi Ma; Yunfu Deng; Dan Pu; Zhenkun Liu; Qiang Wu; Xuejuan Liu; Qinghua Zhou
Journal:  Sci Rep       Date:  2020-04-20       Impact factor: 4.379

8.  Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer.

Authors:  Katsuhiko Shimizu; Riki Okita; Shinsuke Saisho; Takuro Yukawa; Ai Maeda; Yuji Nojima; Masao Nakata
Journal:  Ther Clin Risk Manag       Date:  2015-10-08       Impact factor: 2.423

9.  A comparison of inflammation markers for predicting oncological outcomes after surgical resection of non-small-cell lung cancer: a validated analysis of 2,066 patients.

Authors:  Hsiang-Ling Wu; Yu-Ming Wu; Jui-Tai Chen; Kuang-Yi Chang; Yih-Giun Cherng; Shih-Pin Lin; Mei-Yung Tsou; Ying-Hsuan Tai
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.